vs

Side-by-side financial comparison of CIVITAS RESOURCES, INC. (CIVI) and Steris (STE). Click either name above to swap in a different company.

Steris is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.3× CIVITAS RESOURCES, INC.). On growth, Steris posted the faster year-over-year revenue change (9.2% vs -8.2%). Over the past eight quarters, Steris's revenue compounded faster (15.8% CAGR vs 1.8%).

Civitas Resources, Inc. is a U.S.-based sustainable energy enterprise focused on the exploration, development, and production of oil, natural gas, and natural gas liquids. It primarily operates across the Denver-Julesburg Basin in Colorado, prioritizing low-emission, responsible energy production to meet diverse North American energy demand.

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

CIVI vs STE — Head-to-Head

Bigger by revenue
STE
STE
1.3× larger
STE
$1.5B
$1.2B
CIVI
Growing faster (revenue YoY)
STE
STE
+17.3% gap
STE
9.2%
-8.2%
CIVI
Faster 2-yr revenue CAGR
STE
STE
Annualised
STE
15.8%
1.8%
CIVI

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
CIVI
CIVI
STE
STE
Revenue
$1.2B
$1.5B
Net Profit
$192.9M
Gross Margin
43.8%
Operating Margin
20.0%
18.3%
Net Margin
12.9%
Revenue YoY
-8.2%
9.2%
Net Profit YoY
11.2%
EPS (diluted)
$1.99
$1.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIVI
CIVI
STE
STE
Q4 25
$1.5B
Q3 25
$1.2B
$1.5B
Q2 25
$1.1B
$1.4B
Q1 25
$1.2B
$1.5B
Q4 24
$1.3B
$1.4B
Q3 24
$1.3B
$1.3B
Q2 24
$1.3B
$1.3B
Q1 24
$1.3B
$1.1B
Net Profit
CIVI
CIVI
STE
STE
Q4 25
$192.9M
Q3 25
$191.9M
Q2 25
$177.4M
Q1 25
$145.7M
Q4 24
$173.5M
Q3 24
$150.0M
Q2 24
$145.4M
Q1 24
$-1.4M
Gross Margin
CIVI
CIVI
STE
STE
Q4 25
43.8%
Q3 25
44.2%
Q2 25
45.1%
Q1 25
43.3%
Q4 24
44.5%
Q3 24
43.6%
Q2 24
44.7%
Q1 24
40.2%
Operating Margin
CIVI
CIVI
STE
STE
Q4 25
18.3%
Q3 25
20.0%
18.2%
Q2 25
15.3%
17.7%
Q1 25
20.7%
14.6%
Q4 24
15.4%
17.9%
Q3 24
30.6%
16.5%
Q2 24
21.6%
14.5%
Q1 24
15.9%
22.0%
Net Margin
CIVI
CIVI
STE
STE
Q4 25
12.9%
Q3 25
13.1%
Q2 25
12.8%
Q1 25
9.8%
Q4 24
12.7%
Q3 24
11.3%
Q2 24
11.4%
Q1 24
-0.1%
EPS (diluted)
CIVI
CIVI
STE
STE
Q4 25
$1.96
Q3 25
$1.99
$1.94
Q2 25
$1.34
$1.79
Q1 25
$1.99
$1.48
Q4 24
$1.56
$1.75
Q3 24
$3.01
$1.51
Q2 24
$2.15
$1.46
Q1 24
$1.74
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIVI
CIVI
STE
STE
Cash + ST InvestmentsLiquidity on hand
$56.0M
$423.7M
Total DebtLower is stronger
$5.1B
$1.9B
Stockholders' EquityBook value
$6.7B
$7.2B
Total Assets
$15.1B
$10.6B
Debt / EquityLower = less leverage
0.77×
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIVI
CIVI
STE
STE
Q4 25
$423.7M
Q3 25
$56.0M
$319.2M
Q2 25
$69.0M
$279.7M
Q1 25
$20.0M
$171.7M
Q4 24
$76.0M
$155.2M
Q3 24
$47.1M
$172.2M
Q2 24
$91.9M
$198.3M
Q1 24
$52.1M
$207.0M
Total Debt
CIVI
CIVI
STE
STE
Q4 25
$1.9B
Q3 25
$5.1B
$1.9B
Q2 25
$5.4B
$1.9B
Q1 25
$5.1B
$1.9B
Q4 24
$4.5B
$2.0B
Q3 24
$4.8B
$2.2B
Q2 24
$4.9B
$2.2B
Q1 24
$4.4B
$3.1B
Stockholders' Equity
CIVI
CIVI
STE
STE
Q4 25
$7.2B
Q3 25
$6.7B
$7.0B
Q2 25
$6.8B
$7.0B
Q1 25
$6.7B
$6.6B
Q4 24
$6.6B
$6.4B
Q3 24
$6.7B
$6.6B
Q2 24
$6.6B
$6.4B
Q1 24
$6.6B
$6.3B
Total Assets
CIVI
CIVI
STE
STE
Q4 25
$10.6B
Q3 25
$15.1B
$10.4B
Q2 25
$15.4B
$10.4B
Q1 25
$15.3B
$10.1B
Q4 24
$14.9B
$10.0B
Q3 24
$15.0B
$10.2B
Q2 24
$15.0B
$10.1B
Q1 24
$15.1B
$11.1B
Debt / Equity
CIVI
CIVI
STE
STE
Q4 25
0.27×
Q3 25
0.77×
0.27×
Q2 25
0.79×
0.27×
Q1 25
0.76×
0.29×
Q4 24
0.68×
0.32×
Q3 24
0.73×
0.33×
Q2 24
0.74×
0.35×
Q1 24
0.67×
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIVI
CIVI
STE
STE
Operating Cash FlowLast quarter
$860.0M
$298.2M
Free Cash FlowOCF − Capex
$199.5M
FCF MarginFCF / Revenue
13.3%
Capex IntensityCapex / Revenue
6.6%
Cash ConversionOCF / Net Profit
1.55×
TTM Free Cash FlowTrailing 4 quarters
$917.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIVI
CIVI
STE
STE
Q4 25
$298.2M
Q3 25
$860.0M
$287.8M
Q2 25
$298.0M
$420.0M
Q1 25
$719.0M
$260.8M
Q4 24
$858.2M
$332.8M
Q3 24
$835.0M
$250.7M
Q2 24
$359.0M
$303.7M
Q1 24
$813.0M
$254.8M
Free Cash Flow
CIVI
CIVI
STE
STE
Q4 25
$199.5M
Q3 25
$201.3M
Q2 25
$326.4M
Q1 25
$189.9M
Q4 24
$243.6M
Q3 24
$148.8M
Q2 24
$195.7M
Q1 24
$163.3M
FCF Margin
CIVI
CIVI
STE
STE
Q4 25
13.3%
Q3 25
13.8%
Q2 25
23.5%
Q1 25
12.8%
Q4 24
17.8%
Q3 24
11.2%
Q2 24
15.3%
Q1 24
14.6%
Capex Intensity
CIVI
CIVI
STE
STE
Q4 25
6.6%
Q3 25
5.9%
Q2 25
6.7%
Q1 25
4.8%
Q4 24
6.5%
Q3 24
7.7%
Q2 24
8.4%
Q1 24
8.2%
Cash Conversion
CIVI
CIVI
STE
STE
Q4 25
1.55×
Q3 25
1.50×
Q2 25
2.37×
Q1 25
1.79×
Q4 24
1.92×
Q3 24
1.67×
Q2 24
2.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CIVI
CIVI

Crude Oil Natural Gas And Natural Gas Liquids$1.2B99%
Oil And Gas Operation And Maintenance$8.0M1%
Natural Gas Reserves$2.0M0%

STE
STE

Servicerevenues$404.7M27%
Consumablerevenues$387.1M26%
Applied Sterilization Technologies$286.6M19%
Capitalequipmentrevenues$272.1M18%
Life Science$145.8M10%

Related Comparisons